1.3.99.6: 3-oxo-5beta-steroid 4-dehydrogenase
This is an abbreviated version!
For detailed information about 3-oxo-5beta-steroid 4-dehydrogenase, go to the full flat file.
Word Map on EC 1.3.99.6
-
1.3.99.6
-
5alpha-reductase
-
5alpha
-
11beta-hydroxysteroid
-
akr1d1
-
5beta-reduced
-
delta4-3-ketosteroids
-
3alpha-hsds
-
songbird
-
analysis
- 1.3.99.6
-
5alpha-reductase
-
5alpha
- 11beta-hydroxysteroid
- akr1d1
-
5beta-reduced
- delta4-3-ketosteroids
- 3alpha-hsds
-
songbird
- analysis
Reaction
Synonyms
3-keto-DELTA4-steroid-5beta-reductase, 3-oxo-5beta-steroid DELTA4-dehydrogenase, 3-oxo-DELTA4-steroid-5beta-reductase, 5beta-reductase, AKR1D1, Aldo-keto reductase family 1 member D1, Delta(4)-3-ketosteroid 5-beta-reductase, DELTA-3-ketosteroid-5beta-reductase, DELTA4-3-ketosteroid-5beta-reductase, DELTA4-3-oxosteroid 5beta-reductase, DELTA4-5beta-DH, steroid 5beta reductase, steroid 5beta-reductase, steroid DELTA-5beta-dehydrogenase, testosterone 5beta-reductase
ECTree
Advanced search results
Disease
Disease on EC 1.3.99.6 - 3-oxo-5beta-steroid 4-dehydrogenase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
3-oxo-5beta-steroid 4-dehydrogenase deficiency
Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency.
3-oxo-5beta-steroid 4-dehydrogenase deficiency
Diagnosis of the first Japanese patient with 3-oxo-delta4-steroid 5beta-reductase deficiency by use of immunoblot analysis.
3-oxo-5beta-steroid 4-dehydrogenase deficiency
Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
3-oxo-5beta-steroid 4-dehydrogenase deficiency
SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect.
3-oxo-5beta-steroid 4-dehydrogenase deficiency
SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta-steroid 5beta-reductase deficiency.
Carcinoma, Hepatocellular
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.
Carcinoma, Hepatocellular
Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants.
Cholestasis
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.
Cholestasis
Diagnosis of the first Japanese patient with 3-oxo-delta4-steroid 5beta-reductase deficiency by use of immunoblot analysis.
Cholestasis
SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta-steroid 5beta-reductase deficiency.
Essential Hypertension
11beta-hydroxysteroid dehydrogenase type-2 and type-1 (11beta-HSD2 and 11beta-HSD1) and 5beta-reductase activities in the pathogenia of essential hypertension.
Fatty Liver
Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Hepatitis
Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
Hyperandrogenism
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.
Liver Diseases
Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
Liver Failure
Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
Non-alcoholic Fatty Liver Disease
Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Obesity
Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.
Polycystic Ovary Syndrome
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.
html completed